The co-founder of France's far-right National Front, Jean-Marie Le Pen, faces trial for inciting racial hatred over a swipe at a Jewish singer that was seen as anti-Semitic, judicial sources said Tuesday (18 July).
French prosecutors are probing the far-right National Front (FN) for suspected fraud linked to payments for aides at the European Parliament, judicial sources said yesterday (5 December), as the party struggles to find all-important funding.
The European Parliament on Tuesday (25 October) voted to lift Jean-Marie Le Pen's parliamentary immunity. The move follows a request from French prosecutors, who are building a case against Le Pen for inciting racial hatred.
French newspaper Libération has teamed up with the Jean Jaurès foundation, a think tank, and the communications agency Netscouade to launch an observatory of the National Front, to look into the reasons behind the party’s growth and recent success. EURACTIV France reports.
After a fairly restless summer, the mood on Brexit has shifted in Brussels. Initial disbelief that the UK could have voted to leave is now replaced by acceptance that, “Brexit means Brexit”, writes Andrew Duff.
The European Parliament is demanding the repayment of €320,000 from MEP Jean-Marie Le Pen over a salary it believes was wrongly paid out to a parliamentary assistant, sources said on Wednesday (22 June).
Nearly half of Austrian voters ended up voting for far-right presidential candidate Norbert Hofer, showing that European right-wing populism's time in the sun is far from over. EURACTIV’s partner Der Tagesspiegel reports.
The French extreme right party has denounced tax evasion in the European Parliament, but several of Jean-Marie Le Pen’s close contacts have been implicated in the Panama Papers. EURACTIV France reports.
The French National Front has punished Jean-Marie Le Pen for describing the gas chambers of the Holocaust as a "detail" of history, but enforcing discipline among their European Parliament allies could prove harmful to their fledgling political group. EURACTIV France reports.
Marine Le Pen has presented her new Polish and British allies, who will be propping up her group in the European Parliament. But the details of their political programme are yet to be defined. EURACTIV France reports.
Tensions between French National Front leader Marine Le Pen and her father Jean-Marie worsened on Thursday as the 86-year-old founder of the far-right party defended having described Nazi gas chambers as a "detail of history".
Parliament is trying to clamp down on lawmakers employing excessive numbers of assistants. Among those with particularly high numbers of are Polish, Lithuanian, Bulgarian, Romanian and Eurosceptic MEPs. EURACTIV France reports.
Despite tensions caused by Jean-Marie Le Pen's most recent anti-Semitic outburst, the National Front is picking up the tempo on talks to form a political group in the European Parliament. EURACTIV France reports.
The European Jewish Congress has called on the European Union to remove Jean-Marie Le Pen’s parliamentary immunity after the former leader of the French National Front made remarks reviving long-standing allegations of anti-Semitism.
The new leader of France's National Front, Marine Le Pen, warned skinheads to stay away from its annual labour day parade this weekend, stepping up efforts to improve the far-right party's image ahead of elections next year.
New Front National leader Marine Le Pen will campaign against Brussels as a threat to French independence, heritage and jobs, Sylvain Crépon, a researcher at Nanterre University and an expert on the far right, told EURACTIV.fr in an interview.
The need for fast, accurate and balanced information is always important. We value EURACTIV's good, independent journalism and support this initiative
Mella Frewen, Director General of FoodDrinkEurope
EURACTIV plays a vital role in bringing Europe closer to its citizens. EURACTIV has long recognised that the story of Europe has to be told across the continent, and not just in Brussels. We need to support a truly European and informed debate.